| | Class 3 Device Recall COBAS INTEGRA Cyclosporine Assay |  |
| Date Initiated by Firm | August 13, 2010 |
| Date Posted | April 15, 2011 |
| Recall Status1 |
Terminated 3 on May 04, 2011 |
| Recall Number | Z-1998-2011 |
| Recall Event ID |
56636 |
| Product Classification |
Cyclosporine - Product Code MKW
|
| Product | Cyclosporine Sample Pretreatment Reagent, COBAS INTEGRA, IVD, Roche Diagnostics GmbH, Assembled for and Distributed by: Roche Diagnostics Corporation, Indianapolis, IN.
For the quantitative determination of Cyclosporine in whole blood, using automated clinical analyzers as an aid in management of therapy in kidney, liver, and heart transplants |
| Code Information |
Lot number: 70002500 |
Recalling Firm/ Manufacturer |
Roche Diagnostics Operations, Inc. 9115 Hague Road Indianapolis IN 46256-1025
|
| For Additional Information Contact | Betsy Cox 317-521-3911 Ext. 249 |
Manufacturer Reason for Recall | The cyclosporine sample pretreatment reagent lot was assigned an incorrect expiration date. |
FDA Determined Cause 2 | Other |
| Action | Roche Diagnostics Corporation sent an Urgent Medical Device Removal letter dated 8/13/2011, by UPS ( signature required ) to the consignees. The letter identified the product, the problem, and the action to be taken by the consignee.
Consignees were instructed to discontinue use of affected product upon receipt of replacement product.
Consignees were instructed to dispose of the product at their facilities. Therefore, no product returns are anticipated.
Questions concerning this recall please call (317) 521-3911. |
| Quantity in Commerce | 22 kits |
| Distribution | Nationwide Distribution -- including, IN, NJ, NY, TX, CA, PA, OH, and FL. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|